Extension and rate of lymph node invasion of pelvic lymph node dissection during robot-assisted radical prostatectomy according to D'Amico classification. An analysis of a single-center experience
Altro
Data di Pubblicazione:
2014
Citazione:
Extension and rate of lymph node invasion of pelvic lymph node dissection during robot-assisted radical prostatectomy according to D'Amico classification. An analysis of a single-center experience / E. De Lorenzis, B. Rocco, G. Albo, D. Buniato, M. Spinelli, P. Dell'Orto, F..G..P. Acquati, M. Rosso, F. Rocco. ((Intervento presentato al 87. convegno Congresso Nazionale Società Italiana di Urologia (SIU) tenutosi a Firenze nel 2014.
Abstract:
Aim of the study
Pelvic lymph node dissection (PLND) is the most accurate staging procedure for patients diagnosed with
organ-confined prostate cancer who undergo radical prostatectomy. Several studies showed that an extended
PLND is feasible during robotic assisted radical prostatectomy (RARP). To evaluate extension of PLND
and lymph nodes metastasis rates, according to D’Amico’s classification, in patient underwent to RARP and
PLND in our Institution.
Materials and methods
Between January 2011 to March 2013, 286 patients underwent RARP in our Institution. Of these, 173 were
evaluable for the analysis. We retrospectively reviewed our prospectively collected database and stratified
patients into 3 groups according to D’Amico classification. Then we performed a comparison between
standard (sPLND) versus extended PLND (ePLND).
Results
The preoperative characteristics of the patients are shown in table 1. According to d’Amico classification,
45 patients (26%) were classified as high risk, 60 patients (35%) as intermediate risk while the remaining 68
patients (39%) were low risk. Overall, PLND was performed in 72 patients (41.6%). Of these, 37 were high
risk (51.4%), 34 intermediate risk (47.2%) and one patient was low risk (1.4%). In the high risk group, 37/45
patients (82.2%) underwent PLND, 34/60 (56.7%) in the intermediate group and 1/68 (1.5%) in the low risk
group. The mean number of nodes removed was overall 17.25+/-11.1; 17.05+/- 7.7 in the high risk group,
17.27+/-14.1 in the intermediate risk group and 24 in the low risk group. Among patients who performed
PLND, lymph node invasion (LNI) was found in 15 patients (20.8%). LNI was found in zero, 5 (14.5%),
and 10 (27%) of the low, intermediate, and high risk patients who underwent PLND, respectively ( table 2)
ePLND was performed in 22/72 patients (30.5%). The mean number of nodes removed was 14.06 +/-7.3 for
the sPLND and 24.36 +/-14.6 for the ePLND. LNI was observed in the 16.3% of sPLND and in the 27.3%
of ePLND. The lymph nodes density was 2.3% for sPLND and 2.0% for ePLND.
Discussion
In our cohort we observed a higher rate of LNI to those reported in literature, especially in high risk patients.
As expected, ePLND is associated with high number of lymph nodes removed. The strengths of this
study are the stratification into risk groups and the comparison between standard and extended PLND; all
specimens were analysed by expert pathologists. Limitations of this study are its retrospective design and the
limited number of patients included.
Conclusions
In our experience, the lymph node yeld in the robotic setting is satisfactory. The extended template of PLND
improves staging and increases detection rate of LNI. D’Amico risk classification can be considered a good
predictor of LNI in patients undergoing PLND during RARP.
Tipologia IRIS:
14 - Intervento a convegno non pubblicato
Elenco autori:
E. De Lorenzis, B. Rocco, G. Albo, D. Buniato, M. Spinelli, P. Dell'Orto, F..G..P. Acquati, M. Rosso, F. Rocco
Link alla scheda completa: